MedPath

Furosemide effect on pregnancy hypertensio

Phase 2
Conditions
Sever preeclampsia.
Severe pre-eclampsia
Registration Number
IRCT2012082610674N1
Lead Sponsor
Vice chancellor for research, Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
100
Inclusion Criteria

Prim gravid patients; Sever preeclampsia
Exclusion criteria: Chronic hypertension history; Renal disease; Mellitus diabetes; Smoking; Cardiovascular disease; Twin pregnancy.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hypertension. Timepoint: Q4h. Method of measurement: Mercury sphygmomanometer(mmgh).
Secondary Outcome Measures
NameTimeMethod
Electrolyte imbalance. Timepoint: Daily. Method of measurement: Laboratory.
© Copyright 2025. All Rights Reserved by MedPath